Contents

Anti-Cancer Agents in Medicinal Chemistry, Volume 9 - Number 5

Potential of Selective Estrogen Receptor Modulators as Treatments and Preventives of Breast Cancer

, 9(5): 481 - 499

Jing Peng, Surojeet Sengupta and V. Craig Jordan


DOI: 10.2174/187152009788451833




Actual and Potential Agents and Biomarkers in the Treatment of Cancer

, 9(5): 500 - 516

M. P. Carrera, M. J. Ramirez-Exposito and J. M. Martinez-Martos


DOI: 10.2174/187152009788451824




Role of Oxygen in Cancer: Looking Beyond Hypoxia

, 9(5): 517 - 525

Miguel Lopez-Lazaro


DOI: 10.2174/187152009788451806




The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets

, 9(5): 526 - 542

Andrew J. Wiemer, Raymond J. Hohl and David F. Wiemer


DOI: 10.2174/187152009788451860




Can the Status of the Breast and Ovarian Cancer Susceptibility Gene 1 Product (BRCA1) Predict Response to Taxane-Based Cancer Therapy?

, 9(5): 543 - 549

J. Thomas DeLigio, Aneliya Velkova, Diego A.R. Zorio and Alvaro N.A. Monteiro


DOI: 10.2174/187152009788451798




The PI3K/Akt Pathway as a Target in the Treatment of Hematologic Malignancies

, 9(5): 550 - 559

Kiyotaka Kawauchi, Toshie Ogasawara, Masako Yasuyama, Kuniaki Otsuka and Osamu Yamada


DOI: 10.2174/187152009788451851




The Effect of Lipoic Acid on Macro and Trace Metal Levels in Living Tissues Exposed to Oxidative Stress

, 9(5): 560 - 568

Harun Ciftci and Unal Bakal


DOI: 10.2174/187152009788451815




Role of Tyrosine Kinase Inhibitors in Lung Cancer

, 9(5): 569 - 575

J. Ansari, D. H. Palmer, D. W. Rea and S. A. Hussain


DOI: 10.2174/187152009788451879




Control of Melanoma Invasiveness by Anticollagenolytic Agents: A Reappraisal of an Old Concept

, 9(5): 576 - 597

Erika Bourguet, Janos Sapi, Herve Emonard and William Hornebeck


DOI: 10.2174/187152009788451842




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science